[Effect of Tranquo-Alupent in asthmatic syndrome].
D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy; D001982:Bronchial Diseases / Q000188:drug therapy*; D001987:Bronchiectasis / Q000188:drug therapy; D001991:Bronchitis / Q000188:drug therapy; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D008297:Male; D009921:Metaproterenol / Q000627:therapeutic use; D008875:Middle Aged; D010076:Oxazepam / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D012118:Resorcinols / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol; D010076:Oxazepam
Zur Wirkung von Tranquo-Alupent beim asthmatischen Syndrom.